Lymphoma News

lls.png
The Leukemia & Lymphoma Society (LLS), along with Janssen Research & Development, LLC, are committing $1.7 million to...
bankofamerica.jpg
A lawsuit filed in the Marshall Division of the Eastern District of Texas in September claims that the bank fired a woman bec...
biovestintl.jpg
Biovest, makers of BiovaxID, an immunotherapy and a therapeutic vaccine to treat follicular non-Hodgkin's lymphoma, has reach...
CityofHope.jpg
Already a leader in the field of stem cell transplants, the Los Angeles area hospital's commitment to blood disorders grows e...
IMF.jpg
Last month, members of the International Myeloma Foundation (IMF) held a congressional briefing to draw attention to the risk...
Quessenberry.png
David Quessenberry, the 24-year-old offensive tackle for the Houston Texans currently battling non-Hodgkin's lymphoma, served...
akynzsm.png
The US Food and Drug Administration today approved Akynzeo (netupitant and palonosetron) to treat nausea and vomiting in pati...
velcade-product.png
According to the manufacturer, Velcade (bortezomib) has been approved by the US FDA in combination with other drugs for the t...
soligenix.jpg
Biopharmaceutical firm Soligenix has entered into an agreement with the US Food and Drug Administration (FDA) on the design o...
adcetris.png
Seattle Genetics, along with partner Takeda Pharmaceutical Company Ltd., is announcing positive top-line data from the random...

LymphomaInfo Social